4
Changes in Ownership
Axogen, Inc. Filed Acc 0000805928-23-000138
Chief R&D Officer returned 1,403 shares (to the company)
- Chief R&D Officer acquired 2,571 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Scopelianos Angelo Chief R&D Officer | 2023-07-18 | Grant or award | +2,571 | 38,372 | D: show line 1 in the form | ||
| Scopelianos Angelo Chief R&D Officer | 2023-10-13 | Returned to the company | −1,403 | $4.04 | $5,668 | 36,969 | D: show line 2 in the form |
Loading xslF345X05/wk-form4_1697243312.xml…